Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Mutat Res ; 493(1-2): 115-26, 2001 Jun 27.
Article in English | MEDLINE | ID: mdl-11516721

ABSTRACT

Norharman, abundantly present in cigarette smoke and cooked foods, is not mutagenic to Salmonella typhimurium strains. However, norharman shows mutagenicity to S. typhimurium TA98 and YG1024 in the presence of S9 mix when coexisting with aromatic amines, including aniline, o- and m-toluidines. We previously reported that the mutagenicity from norharman and aniline in the presence of S9 mix was due to the formation of a mutagenic compound, 9-(4'-aminophenyl)-9H-pyrido[3,4-b]indole (aminophenylnorharman). In the present study, we analyzed the mutagens produced by norharman with o- or m-toluidine in the presence of S9 mix. When norharman and o-toluidine were reacted at 37 degrees C for 20 min, two mutagenic compounds, which were mutagenic with and without S9 mix, respectively, were produced, and these were isolated by HPLC. The former mutagen was deduced to be 9-(4'-amino-3'-methylphenyl)-9H-pyrido[3,4-b]indole (amino-3'-methylphenylnorharman) on the basis of various spectral data, and this new heterocyclic amine was confirmed by its chemical synthesis. The latter mutagen was identified to be the hydroxyamino derivative. Amino-3'-methylphenylnorharman induced 41,000 revertants of TA98, and 698,000 revertants of YG1024 per microg with S9 mix. Formation of the same DNA adducts was observed in YG1024 when amino-3'-methylphenylnorharman or a mixture of norharman plus o-toluidine was incubated with S9 mix. These observations suggest that norharman reacts with o-toluidine in the presence of S9 mix to produce amino-3'-methylphenylnorharman, and this compound is metabolically activated to yield its hydroxyamino derivative. After activation by O-acetyltransferase, it might bind to DNA and exert mutagenicity in S. typhimurium TA98 and YG1024. When norharman and m-toluidine were reacted in the presence of S9 mix, 9-(4'-amino-2'-methylphenyl)-9H-pyrido[3,4-b]indole (amino-2'-methylphenylnorharman) was identified as a mutagen. Thus, the mutagenicity of norharman with m-toluidine may follow a mechanism similar to that with o-toluidine.


Subject(s)
Harmine/chemistry , Harmine/toxicity , Mutagens/chemistry , Mutagens/toxicity , Toluidines/chemistry , Toluidines/toxicity , Animals , Biotransformation , Carbolines , Chromatography, High Pressure Liquid , DNA Adducts/drug effects , Harmine/administration & dosage , Harmine/analogs & derivatives , Harmine/pharmacokinetics , In Vitro Techniques , Magnetic Resonance Spectroscopy , Microsomes, Liver/metabolism , Mutagens/administration & dosage , Rats , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics , Toluidines/administration & dosage
2.
Int Dent J ; 48(6): 563-70, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9881290

ABSTRACT

The standardised mortality ratios (SMR) were obtained for dentists in Tokyo according to the causes of their deaths, in order to compare them with those for general Tokyo citizens. Furthermore, an abridged life table was prepared and those dentists' life expectancies were estimated. The materials used were 560 death certificates for male dentists issued in the 10-year period 1985-1994. The documents were kept at the Health Insurance Co-operative Society for Tokyo Dentists, run by the Tokyo Dental Association (TDA). With the general Tokyo residents as a reference population, the SMRs for dentists were significantly higher for oesophageal and colon cancers and significantly lower for heart diseases and pneumonia/bronchitis. The life expectancy for a 25-year-old dentist in Tokyo was 51.26 years. That at birth was stochastically estimated at 75.37 years, which was some one year shorter than that for an ordinary inhabitant (76.67 years), though the difference was insignificant.


Subject(s)
Cause of Death , Dentists/statistics & numerical data , Life Expectancy , Mortality , Adult , Age Distribution , Aged , Aged, 80 and over , Bronchitis/mortality , Colonic Neoplasms/mortality , Death Certificates , Esophageal Neoplasms/mortality , Female , Heart Diseases/mortality , Humans , Life Tables , Male , Middle Aged , Pneumonia/mortality , Stochastic Processes , Tokyo/epidemiology
3.
J Leukoc Biol ; 61(1): 50-7, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9000536

ABSTRACT

We have shown previously that a calcium-binding protein complex, calprotectin, derived from polymorphonuclear leukocytes exerts a cytostatic and cytolytic effect against a very broad range of tumor cell lines. We also described that calprotectin is an apoptosis-inducing factor for certain tumor cells and that zinc ion attenuates the calprotectin activities. The titers of the factor in body fluids are known to increase greatly in various types of inflammation. In this study, to learn the role of calprotectin in inflammation, the growth-inhibitory and the apoptosis-inducing activities of the factor against normal fibroblasts were examined because fibroblasts are a cell type constituting a local inflammatory site. Rat calprotectin inhibited the growth of murine embryonic as well as human dermal fibroblasts. Although calprotectin induced apoptotic morphology in both fibroblasts, the reaction was slower and less efficient than cases using tumor cells as targets. The activities were significantly abrogated by 10-50 microM Zn2+, Cu2+, Mn2+, or Fe2+, respectively, whereas the trivalent cations Al3+ and Fe3+ had no effect. The dose-response curves of the calprotectin effects were shifted to about 10-fold lower concentration ranges in the divalent metal ion-depleted medium. These results suggest that calprotectin extracellularly affects the inflammatory processes by modulating the growth and survival states of normal fibroblasts, and that the effects are physiologically controlled by several metal ions.


Subject(s)
Apoptosis/drug effects , Calcium-Binding Proteins/pharmacology , Fibroblasts/drug effects , Metals/pharmacology , Neural Cell Adhesion Molecules/pharmacology , Animals , Calcium/pharmacology , Calcium-Binding Proteins/antagonists & inhibitors , Cell Division/drug effects , Fibroblasts/cytology , Humans , Leukocyte L1 Antigen Complex , Magnesium/pharmacology , Male , Mice , Rats , Zinc/pharmacology
6.
Dent Jpn (Tokyo) ; : 57-67, 1969 Oct.
Article in English | MEDLINE | ID: mdl-5263472

Subject(s)
Insurance, Dental
SELECTION OF CITATIONS
SEARCH DETAIL
...